Columbia
Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial
The trial will study the use of Foresight's Clarity MRD assay in identifying early treatment responders for therapy de-escalation.
Bacteria Harness Reverse Transcriptase to Make Novel Genes From Noncoding RNA
Researchers identified a defense-associated reverse transcriptase system dubbed DRT2 that uses noncoding RNA and programmed template jumping to produce new, protein-coding immune genes.
New York State Awards $3M to Researchers for Infectious Disease Tool Innovations
Teams from Rover Diagnostics, Mount Sinai, Columbia University, and Niagara University are the third round of awardees of the state’s Biodefense Commercialization Fund.
Genetic Variant Effects on Gene Expression Mapped in Elderly Human Brains
Researchers used single-cell transcriptomics in dorsolateral prefrontal cortex cells from elderly participants, including Alzheimer's patients.
Liquid Biopsy-Based Colorectal Cancer Screening Lacks Cost-Effectiveness, Economic Analysis Finds
A simulation study suggests colonoscopy remains the most cost-effective CRC screening method, as liquid biopsy carries a far higher price per life-year gained.